Cover Image
市場調查報告書

3D生物印刷市場 (2017-2027年):技術、市場、預測

3D Bioprinting 2017-2027: Technologies, Markets, Forecasts

出版商 IDTechEx Ltd. 商品編碼 300641
出版日期 內容資訊 英文 184 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
3D生物印刷市場 (2017-2027年):技術、市場、預測 3D Bioprinting 2017-2027: Technologies, Markets, Forecasts
出版日期: 2017年05月09日 內容資訊: 英文 184 Pages
簡介

3D生物印刷的市場是2027年18億美元的規模成長。

本報告提供全球3D生物印刷的技術及市場調查,3D生物印刷定義和概要,主要市場趨勢,市場成長的各種影響因素分析,目前的技術、生物學課題,主要的競爭技術,主要技術、新興技術、相關技術類型和概要,各種用途,市場規模的變化與預測,再生醫療領域的詳細分析,以及主要企業的簡介等彙整。

第1章 摘要整理

第2章 簡介

  • 報告範圍、3D生物印刷定義
  • 3D生物印刷的流程
  • 三次元細胞培養的優點
  • 3D生物印刷的優點
  • 主要的成長推動因素:再生醫療
  • 主要的成長推動因素:醫藥領域的產品檢驗
  • 主要的成長推動因素:消費品領域的產品檢驗
  • 主要趨勢:3D生物印表機
  • 主要趨勢:生物印刷組織
  • 主要的競爭技術
  • 目前技術課題
  • 目前生物學的課題
  • 法律規章上的門檻
  • SWOT分析

第3章 3D生物印表機技術

  • 從3D列印到3D生物印刷
  • 3D生物印刷技術
    • 主要的規格比較
  • 3D生物印刷技術比較
  • 噴墨:簡介
    • 主要的規格
    • 熱動式
    • 壓電式
    • 優點
    • 課題
    • SWOT分析
  • 押出成型:簡介
    • 主要的規格
    • 氣壓式
    • 機器式
    • 優點
    • 課題
    • SWOT分析
  • 雷射:簡介
    • 主要的規格
    • 雷射誘導前方轉印
    • 優點
    • 課題
    • SWOT分析
  • 微閥門:簡介
    • 主要的規格
    • 螺線管
    • 優點
    • 課題
    • SWOT分析
  • 新興技術
    • 電紡
    • 微規模連續光學生物印刷 (µCOB)
    • 順磁性、音響
  • 產業整體的技術課題
  • 理想的3D生物印表機
  • 未來技術的方向性

第4章 相關技術

  • 相關技術
  • 3D生物印刷軟體
  • 生物墨水調整
  • 細胞選擇
  • 細胞選擇:再生醫療
  • 成長因素、其他
  • 支架材
  • 理想的支架材
  • 細胞球體印刷
  • 成熟化

第5章 各種用途

  • 簡介
  • 化妝品、其他的消費品的檢驗
  • 藥物篩檢
  • 個人化醫療
  • 再生醫療
  • 細胞為基礎的生物感應器
  • 食品、其他的動物產品
  • 教育
  • 學術研究
  • 生物工學

第6章 市場分析、預測

  • 簡介
  • 3D生物印刷市場成長
  • 市場障礙
  • 主要的撤退者
  • 預測
  • 整體市場預測
  • 價值鏈
  • 3D生物印表機製造商
  • 3D生物印表機市場預測
  • 3D生物印表機市場長期預測
  • 3D生物印刷服務處
  • 3D生物印刷組織的預測
    • 針對消費者產品
    • 醫藥品
    • 其他

第7章 再生醫療

  • 簡介
  • 法律規章上的門檻
  • RMAT (Regenerative Medicine Advanced Therapy Designation)
  • 倫理
  • 詐騙和手法
  • 從實驗室到臨床
  • 3D生物印刷的長期藍圖

第8章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The market for 3D bioprinting will reach $1.8 billion by 2027.

Interest in 3D bioprinting has been gaining momentum in recent years, both in the academic and commercial settings. Between 2014 and 2015, the market welcomed numerous 3D bioprinting companies, and new start-ups, spin-outs, and subsidiaries are continuing to emerge. Though investment in the field has been driven on by the futuristic goal of providing solutions for regenerative by way of fabricating organs for transplant, more realistic applications in product development and testing have shown great promise and are already being marketed. Over 2016, several 3D bioprinting companies saw a doubling of revenue, and comparable results are anticipated for the next few years. Given these market trends, IDTechEx forecasts that the global market for 3D bioprinting will reach a value of $1.8 billion by the year 2027.

                     Source: Source IDTechEx

Technology and Applications

3D bioprinting can be defined in a variety of ways, and each definition includes and excludes large swathes of key biotechnology markets. In this report, IDTechEx has defined 3D bioprinting as the deposition of living cells in a spatially controlled manner in the absence of any pre-existing scaffold and in more than a single layer. Under this definition, 3D bioprinters are currently based on four main printhead technologies:

  • Inkjet
  • Extrusion
  • Laser-induced forward transfer
  • Microvalve

This report profiles each technology and its subtypes, and provides key specifications, vendors, and SWOT analyses. This report also introduces and discusses emerging 3D bioprinting technologies of electrospinning, optical bioprinting, label-less magnetic levitation, and acoustic levitation. Technologies and considerations relevant to the 3D bioprinting process, such as software, bioink (including cell selection, growth factors, and scaffold materials), and post-printing maturation are also discussed.

Current and future applications for 3D bioprinting discussed in this report include:

  • Testing of cosmetics and other consumer goods
  • Drug screening
  • Personalised medicine
  • Regenerative medicine
  • Cell-based biosensors
  • Food and other animal products
  • Education
  • Academic research
  • Bionics

Regenerative Medicine

Special attention is paid to regenerative medicine in this report, as not only does it have the potential to be the largest application for 3D bioprinting in the future, but also one with the highest impact. This report analyses how 3D bioprinting can be applied to regenerative medicine, and focuses on the following tissue types:

  • Bone and cartilage
  • Skin
  • Dental
  • Vasculature
  • Complex organs

Additionally, discussion of current progress in bringing 3D bioprinted tissues to the clinic is provided, as well future hurdles to be faced. A roadmap of 3D bioprinting in regenerative medicine to the year 2050 is provided.

Forecasts

This report forecasts the overall 3D bioprinting market to 2027, with in depth discussion of key trends in the short term (2017 - 2021), and those expected in the long term (2022 - 2027). Market forecasts to 2027 are also provided for the 3D bioprinter market segmented by price point, and the 3D bioprinted tissue market segmented by tissue application.

Analyst access from IDTechEx

All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1.1. Overview
  • 1.2. 3D Bioprinting Players
  • 1.3. High Profile Partnerships
  • 1.4. Successful Animal Tests
  • 1.5. 3D Bioprinting Market Forecast 2017 - 2027
  • 1.6. 3D Bioprinter Market Forecast 2017 - 2027
  • 1.7. 3D Bioprinted Tissue Market Forecast 2017 - 2027
  • 1.8. Key Drivers
  • 1.9. Key Challenges

2. INTRODUCTION

  • 2.1. Report Scope / 3D Bioprinting Definition
  • 2.2. 3D Bioprinting Process
    • 2.2.1. 3D Bioprinting Process: Discussion
  • 2.3. 3D Cell Culture Advantages
  • 2.4. 3D Bioprinting Advantages
  • 2.5. Key Driver: Regenerative Medicine
    • 2.5.1. Key Driver: Unmet Need in Organs for Transplant
  • 2.6. Key Driver: Product Testing in Medicine
    • 2.6.1. Key Driver: Avoiding Costly Drug Trial Failures
  • 2.7. Key Driver: Product Testing in Consumer Products
  • 2.8. Major Bioprinting Firsts
  • 2.9. 3D Bioprinting in 2017
  • 2.10. Key Trends: 3D Bioprinters
  • 2.11. Key Trends: Bioprinted Tissues
  • 2.12. Key Competing Technologies
  • 2.13. Current Technical Challenges
  • 2.14. Current Biological Challenges
  • 2.15. Regulatory Hurdles
  • 2.16. 3D Bioprinting SWOT Analysis

3. 3D BIOPRINTER TECHNOLOGIES

  • 3.1. From 3D Printing to 3D Bioprinting
  • 3.2. 3D Bioprinting Technologies
    • 3.2.1. Comparison of Key Specifications
  • 3.3. 3D Bioprinting Technology Comparison
  • 3.4. Inkjet: Introduction
    • 3.4.1. Inkjet: Key Specifications
    • 3.4.2. Inkjet: Thermal
    • 3.4.3. Inkjet: Piezoelectric
    • 3.4.4. Inkjet: Advantages
    • 3.4.5. Inkjet: Challenges
    • 3.4.6. Inkjet: SWOT Analysis
  • 3.5. Extrusion: Introduction
    • 3.5.1. Extrusion: Key Specifications
    • 3.5.2. Extrusion: Pneumatic
    • 3.5.3. Extrusion: Mechanical
    • 3.5.4. Extrusion: Advantages
    • 3.5.5. Extrusion: Challenges
    • 3.5.6. Extrusion: SWOT Analysis
  • 3.6. Laser: Introduction
    • 3.6.1. LIFT: Key Specifications
    • 3.6.2. LIFT: Laser-Induced Forward Transfer
    • 3.6.3. LIFT: Advantages
    • 3.6.4. LIFT: Challenges
    • 3.6.5. LIFT: SWOT Analysis
  • 3.7. Microvalve: Introduction
    • 3.7.1. Microvalve: Key Specifications
    • 3.7.2. Microvalve: Solenoid
    • 3.7.3. Microvalve: Advantages
    • 3.7.4. Microvalve: Challenges
    • 3.7.5. Microvalve: SWOT Analysis
  • 3.8. Emerging Technology
    • 3.8.1. Emerging Technology: Electrospinning
    • 3.8.2. Emerging Technology: Microscale Continuous Optical Bioprinting (μCOB)
    • 3.8.3. Emerging Technology: Paramagnetic and Acoustic
  • 3.9. Industry-wide Technical Challenges
  • 3.10. The Ideal 3D Bioprinter
  • 3.11. Future Technological Directions

4. RELATED TECHNOLOGIES

  • 4.1. Related Technologies
  • 4.2. 3D Bioprinting Software
  • 4.3. Bioink Preparation
  • 4.4. Cell Selection
  • 4.5. Cell Selection: Regenerative Medicine
  • 4.6. Growth Factors and Other Additives
  • 4.7. Scaffold Materials
  • 4.8. The Ideal Scaffold Material
  • 4.9. Cell Spheroid Printing
  • 4.10. Maturation

5. APPLICATIONS

  • 5.1. Introduction
  • 5.2. Testing of Cosmetics and Other Consumer Goods
  • 5.3. Drug Screening
    • 5.3.1. Drug Screening: Drug Development Process
  • 5.4. Drug Screening: Benefits of 3D Bioprinting
  • 5.5. Personalised Medicine
  • 5.6. Regenerative Medicine
    • 5.6.1. Regenerative Medicine: Tissue Roadmap
    • 5.6.2. Regenerative Medicine: Bone and cartilage
    • 5.6.3. Regenerative Medicine: Skin
    • 5.6.4. Regenerative Medicine: Dental
    • 5.6.5. Regenerative Medicine: Vasculature
    • 5.6.6. Regenerative Medicine: Complex Organs
  • 5.7. Cell-Based Biosensors
  • 5.8. Food and Other Animal Products
  • 5.9. Education
  • 5.10. Academic Research
  • 5.11. Bionics

6. MARKETS AND FORECASTS

  • 6.1. Introduction
  • 6.2. Growing 3D Bioprinting Market
  • 6.3. Market Barriers
  • 6.4. Key Losers
  • 6.5. Forecasts
  • 6.6. Overall 3D Bioprinting Market Forecast 2017 - 2017
    • 6.6.1. Overall 3D Bioprinting Market Forecast: Short and Long Term
  • 6.7. 3D Bioprinting Value Chain
    • 6.7.1. 3D Bioprinting Value Chain: Discussion
  • 6.8. 3D Bioprinter Manufacturers
    • 6.8.1. 3D Bioprinters by Cost and Technology
  • 6.9. 3D Bioprinter Market Forecast 2017 - 2027
    • 6.9.1. 3D Bioprinter Market Forecast: Short Term
  • 6.9.2. 3D Bioprinter Market Forecast: Long Term
  • 6.10. 3D Bioprinting Service Bureaus
  • 6.11. 3D Bioprinted Tissue Forecast 2017 - 2027
    • 6.11.1. 3D Bioprinted Tissue Forecast: Consumer Products
    • 6.11.2. 3D Bioprinted Tissue Forecast: Pharmaceuticals
    • 6.11.3. 3D Bioprinted Tissue Forecast: Others

7. REGENERATIVE MEDICINE

  • 7.1. Introduction
  • 7.2. Regulatory Hurdles
  • 7.3. Regenerative Medicine Advanced Therapy Designation
  • 7.4. Ethics
  • 7.5. Scams and Schemes
  • 7.6. From Lab to Clinic
  • 7.7. 3D Bioprinting Roadmap to 2050

8. APPENDIX

  • 8.1. List of 3D Bioprinting Companies
  • 8.2. List of Company Profiles
    • 8.2.1. 3D Bioprinting Solutions/Vivax Bio
    • 8.2.2. 3Dynamic Systems Ltd
    • 8.2.3. Aether Inc.
    • 8.2.4. Aspect Biosystems
    • 8.2.5. Biobots
    • 8.2.6. BioDan Group
    • 8.2.7. Cellenion SASU
    • 8.2.8. Cellink
    • 8.2.9. Digilab Inc.
    • 8.2.10. GeSIM
    • 8.2.11. Microdrop Technologies GmbH
    • 8.2.12. MicroFab
    • 8.2.13. Organovo Holdings, Inc.
    • 8.2.14. PeptiGelDesign Ltd
    • 8.2.15. Poietis
    • 8.2.16. Regemat 3D
    • 8.2.17. SE3D
    • 8.2.18. Sichuan Revotek Co. Ltd.
Back to Top